Senior investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in go-to-market strategy, corporate development and board-level governance.
Sarah H. Schmidt brings extensive experience leading cross-functional teams at venture-backed startups and in corporate M&A, advising founders on scaling revenue and capital strategies. Known for sector-driven deal sourcing, portfolio value creation and hands-on operational support to management teams.
Senior investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in go-to-market strategy, corporate development and board-level governance.
Sarah H. Schmidt brings extensive experience leading cross-functional teams at venture-backed startups and in corporate M&A, advising founders on scaling revenue and capital strategies. Known for sector-driven deal sourcing, portfolio value creation and hands-on operational support to management teams.
Growth-oriented investor leveraging operating leadership to back revenue-stage technology and healthcare companies, prioritizing deal flow from sector networks and founder-led teams. Focuses on pragmatic go-to-market and corporate development plays, allocating capital to scalable revenue models with clear path to enterprise adoption. Balances active board-level governance and hands-on operational support with measured capital pacing, emphasizing unit economics, customer retention, and exit optionality over headline valuations.
Growth-oriented investor leveraging operating leadership to back revenue-stage technology and healthcare companies, prioritizing deal flow from sector networks and founder-led teams. Focuses on pragmatic go-to-market and corporate development plays, allocating capital to scalable revenue models with clear path to enterprise adoption. Balances active board-level governance and hands-on operational support with measured capital pacing, emphasizing unit economics, customer retention, and exit optionality over headline valuations.
| Trades 1446 | Longs Won 968/1446 66% | Profit Factor 5.86 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $752,854.49 |
| Average Win $175,874.49 | Best Trade (Aug 17) $21.86M | Sharpe Ratio -9.53 |
| Average Loss -$60,772.54 | Worst Trade (Dec 30) -$4.65M | Z-Score 11.44 (100%) |
| Commissions $0 | Avg. Trade Length 4m 2w 6d | Expectancy $99,720.36 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 19,608 | 17,647 | 15,686 | 13,725 | 11,765 | 9,804 | 7,843 | 5,882 | 3,922 | 1,961 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 1,651 | $219,302 | $228,448.87 | - | $9,146.87 | 4.17% | -0.245% |
AAPL Apple Inc. | 97,815 | $22.47M | $30.22M | - | $7.74M | 34.46% | -7.354% |
ABBV AbbVie Inc. | 3,165 | $717,773.99 | $794,225.1 | - | $76,451.11 | 10.65% | -2.513% |
ABT Abbott Laboratories | 2,453 | $293,939.83 | $259,282.1 | - | -$34,657.73 | -11.79% | +0.085% |
ACYN FT Vest Laddered Autocallable Barrier & Income ETF | 21,465 | $446,257 | $444,110.85 | - | -$2,146.15 | -0.48% | -0.097% |
ACYS FT Vest Laddered Autocallable Barrier & Resilient Income ETF | 19,198 | $394,327 | $392,983.06 | - | -$1,343.94 | -0.34% | -0.146% |
ADI Analog Devices, Inc. | 746 | $296,360 | $274,087.86 | - | -$22,272.14 | -7.52% | +0.202% |
AFL Aflac Inc. | 21,928 | $2.41M | $2.8M | - | $382,407.26 | 15.85% | +0.094% |
AGG iShares Core U.S. Aggregate Bond ETF | 15,420 | $1.54M | $1.5M | - | -$34,758.5 | -2.26% | -0.256% |
AHR American Healthcare REIT, Inc. | 28,126 | $1.33M | $1.56M | - | $231,292 | 17.36% | -0.233% |
AIRR First Trust RBA American Industrial Renaissance ETF | 7,196 | $763,865.78 | $842,291.82 | - | $78,426.04 | 10.27% | +1.588% |
ALGN Align Technology, Inc. | 1,639 | $219,349.68 | $277,253.24 | - | $57,903.56 | 26.4% | -2.451% |
ALL Allstate Corporation | 1,552 | $323,859.84 | $409,852.14 | - | $85,992.3 | 26.55% | -0.49% |
AMAT Applied Materials, Inc. | 2,839 | $740,433.56 | $1.44M | - | $700,841.6 | 94.65% | +1.176% |
AMD Advanced Micro Devices, Inc. | 2,360 | $576,185.61 | $1.12M | - | $547,528.37 | 95.03% | -1.904% |
AMGN Amgen Inc. | 2,129 | $652,135.82 | $820,005.64 | - | $167,869.82 | 25.74% | -0.64% |
AMZN Amazon.com Inc | 37,083 | $7.99M | $10.07M | - | $2.08M | 25.99% | +15.321% |
ANET Arista Networks, Inc. | 1,660 | $203,815.1 | $299,381.02 | - | $95,565.92 | 46.89% | +5.456% |
APH Amphenol Corporation | 3,578 | $226,040.15 | $287,492.3 | - | $61,452.15 | 27.19% | +0.551% |
APP AppLovin Corporation Class A Common Stock | 581 | $231,238 | $230,017.89 | - | -$1,220.11 | -0.53% | -1.973% |